Vaccines and gene therapy for colorectal cancer

Steven Y. Chui, Michael A. Morse

    Research output: Contribution to journalReview article


    Vaccination strategies against colorectal carcinoma attempt to stimulate and direct the body's endogenous immune defense mechanisms against growing malignancies. In similar manner, gene transfer technologies offer the potential to increase the immunogenicity of tumors, confer increased susceptibility to cytotoxic agents, interfere with tumor growth, and correct carcinogenic mutations. With progressive advances in the scientific understanding of carcinogenesis, immune regulation, and the manipulation of immune effector mechanisms at both cellular and molecular levels, vaccines and gene therapies for colon and rectal cancers are now entering preliminary human clinical trials. These novel approaches may eventually offer new treatment possibilities for patients with colorectal malignancies.

    Original languageEnglish (US)
    Pages (from-to)277-292
    Number of pages16
    JournalSeminars in Colon and Rectal Surgery
    Issue number4
    StatePublished - Dec 1 2002


    ASJC Scopus subject areas

    • Surgery
    • Gastroenterology

    Cite this